A process for the preparation of 1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl) piperidine-4-carboxylic acid or its pharmaceutically acceptable salts

Inventor(s)

MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sajja Eswaraiah; Sagyam Rajeshwar Reddy; Sheri Venkata Reddy and Batchanaboina Venkata SubbaiahFollow

Abstract

The present invention relates to a process for the preparation of 1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl] carbamoyl} pyridin-2-yl) piperidine-4-carboxylic acid which is represented by the following structural formula-1 or its pharmaceutically acceptable salts.

Formula-1.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

MSN Laboratories Private Limited, R&D Center; Srinivasan Thirumalai Rajan; Sajja Eswaraiah; Sagyam Rajeshwar Reddy; Sheri Venkata Reddy and Batchanaboina Venkata Subbaiah, "A process for the preparation of 1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl) piperidine-4-carboxylic acid or its pharmaceutically acceptable salts", Technical Disclosure Commons, (October 16, 2023)
https://www.tdcommons.org/dpubs_series/6323